Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Short-course Treatment for Drug-sensitive Tuberculosis in China

NCT05401071 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT05401071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05401071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Short-course Treatment for Drug-sensitive Tuberculosis in China
Lead sponsor
Huashan Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 13, 2023
Completion date
November 1, 2027
Enrollment
2,442 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary